BTIG participated in the Boston Digital Health Innovation Summit 2026 at the Seaport Hotel in Boston, joining investors, venture capitalists, and management teams from firms including Noom, Cityblock, Lark, and Devoted Health to examine the current state and near-term direction of digital health.
The program concentrated on several interrelated themes. Panels explored strategies to manage Medicaid populations by delivering quality care in settings that are cost effective, as well as approaches for Medicare Advantage organizations serving an aging cohort. Sessions also covered ongoing industry activity around obesity and weight-loss interventions.
Artificial intelligence was a recurring topic throughout the event. Speakers described AI as having progressed from a discrete product to an operational foundation that must be woven into clinical workflows, organizational cost structures, and care delivery models. Panelists emphasized that AI initiatives should be directly linked to measurable operational outcomes, such as lowering administrative burden, improving care coordination, and enhancing patient experience. At the same time, participants stressed that human-in-the-loop systems remain important in complex care scenarios.
Attendees also focused on the current capital-raising environment for healthcare technology companies. There was a clear consensus across multiple panels that capital markets have reset. Investors now expect companies approaching an initial public offering to demonstrate the disciplines associated with being a public company before listing. In practice this has translated into demand for stronger governance, predictable execution, repeatable revenue streams, and an explicit path to profitability.
Speakers noted that recent underperformance among Medicare Advantage and other risk-bearing public companies has reinforced a market appetite change. Growth without earnings no longer suffices for favorable valuation or ready access to capital. Instead, durability, cash flow generation, and experienced management teams have become central determinants of company valuation and the ability to attract capital.
Investor and operator dialogue at the summit consistently returned to technology-enabled services, especially models that are value-based and outcomes-oriented. Presenters argued that sustainable defensibility is more likely to accrue to services businesses that can demonstrate outcomes, build trust with members or patients, and sustain longitudinal engagement. Technology-enabled services that leverage automation and AI are viewed as offering better economics than older, more manual services models because they can scale outcomes while managing costs.
BTIG identified a slate of publicly traded healthcare companies that it expects to be well positioned to benefit from these trends. The firms named include Astrana (NASDAQ:ASTH), BrightSpring (NASDAQ:BTSG), Medline (NASDAQ:MDLN), LifeStance (NASDAQ:LFST), LifeMD (NASDAQ:LFMD), The Oncology Institute (NASDAQ:TOI), Veeva (NYSE:VEEV), and Doximity (NYSE:DOCS).
Contextual note - The summit highlighted both strategic and operational themes that investors and operators flagged as defining near-term opportunity and risk in digital health. Attendees consistently linked acceptable capital access to demonstrated operational discipline and clear paths to sustainable economics.